Janus Henderson Group PLC Bridge Bio Pharma, Inc. Transaction History
Janus Henderson Group PLC
- $207 Billion
- Q3 2025
A detailed history of Janus Henderson Group PLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 8,741,079 shares of BBIO stock, worth $580 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
8,741,079
Previous 9,276,532
5.77%
Holding current value
$580 Million
Previous $401 Million
13.34%
% of portfolio
0.22%
Previous 0.21%
Shares
26 transactions
Others Institutions Holding BBIO
# of Institutions
445Shares Held
184MCall Options Held
11.3MPut Options Held
1.84M-
Vanguard Group Inc Valley Forge, PA16.8MShares$1.12 Billion0.01% of portfolio
-
Viking Global Investors LP16MShares$1.06 Billion2.36% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$880 Million27.71% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$826 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA8.19MShares$544 Million1.84% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $9.84B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...